Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS)

AK Mangat, GM Schmölzer, WK Kraft - Seminars in Fetal and Neonatal …, 2019 - Elsevier
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

[HTML][HTML] Pharmacological and Non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS)

AK Mangat, GM Schmölzer, WK Kraft - Seminars in fetal & neonatal …, 2019 - ncbi.nlm.nih.gov
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS).

AK Mangat, GM Schmölzer, WK Kraft - Seminars in Fetal & Neonatal …, 2019 - europepmc.org
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS).

AK Mangat, GM Schmölzer, WK Kraft - 2019 - jdc.jefferson.edu
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS)

AK Mangat, GM Schmölzer… - Seminars in fetal & …, 2019 - pubmed.ncbi.nlm.nih.gov
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS)

AK Mangat, GM Schmölzer, WK Kraft - Seminars in Fetal and …, 2019 - sfnmjournal.com
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

[PDF][PDF] Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS).

AK Mangat, GM Schmölzer, WK Kraft - core.ac.uk
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documents in utero opioid …